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ABSTRACT
Unlike the well-established picture for the entry of
enveloped viruses, the mechanism of cellular entry of
non-enveloped eukaryotic viruses remains largely
mysterious. Picornaviruses are representative models
for such viruses, and initiate this entry process by their
functional receptors. Here we present the structural and
functional studies of SCARB2, a functional receptor of
the important human enterovirus 71 (EV71). SCARB2 is
responsible for attachment as well as uncoating of
EV71. Differences in the structures of SCARB2 under
neutral and acidic conditions reveal that SCARB2
undergoes a pivotal pH-dependent conformational
change which opens a lipid-transfer tunnel to mediate
the expulsion of a hydrophobic pocket factor from the
virion, a pre-requisite for uncoating. We have also
identiﬁed the key residues essential for attachment to
SCARB2, identifying the canyon region of EV71 as
mediating the receptor interaction. Together these
results provide a clear understanding of cellular
attachment and initiation of uncoating for enteroviruses.
KEYWORDS viral entry, uncoating, picornaviruses,
receptor binding, SCARB2, EV71, lipid transfer tunnel
INTRODUCTION
Cell entry of non-enveloped viruses can be accomplished
through two distinct pathways: (a) the endocytic pathway
that employs clathrin-coated vesicles or caveolae; or (b) the
formation of a pore on the cell surface (Hogle, 2002; Iwata
et al., 1991; Marsh and Helenius, 2006; Smith and Helenius,
2004). Picornaviruses are typical non-enveloped viruses and
their entry into the host cell is facilitated mainly through the
endocytic pathway (Tuthill et al., 2010). The process of
Picornavirus ingress can be subdivided into two key steps—
(I) attachment, in which the virus binds to its functional
receptors on the surface of the host cell; and (II) uncoating,
in which the viral genome is released from viral particles into
host cells (Bergelson and Coyne, 2013). Uncoating of many
Picornaviruses requires expulsion of a natural lipid, also
known as “the pocket factor”, from the viral capsid. Removal
of the lipid triggers conformational changes of the capsid,
leading to formation of uncoating intermediates called A
particles (135 S) (Chen et al., 2012; Crowell and Philipson,
1971; Lonberg-Holm et al., 1975; Wang et al., 2012) that
culminates in the release of the N-termini of VP1 (Fricks and
Hogle, 1990; Ren et al., 2013) and all of VP4 (De Sena and
Mandel, 1977). The viral genome is eventually released
through the opening created by this partial disassembly of
the capsid.
Enterovirus 71 (EV71) and Coxsackievirus A16 (CVA16)
are representative members of the enterovirus (EV) genus of
Picornaviruses and are two major causative agents of hand-
foot-and-mouth disease (HFMD) in the Asia-Paciﬁc region
(Huang et al., 1999; Lum et al., 1998; Sun et al., 2013). To
date, two human membrane proteins, P-selectin glycoprotein
ligand-1 (PSGL-1 or CD162) and scavenger receptor class B
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2 (SCARB2 or CD36-like-2), have been identiﬁed as func-
tional receptors for EV71 (Nishimura et al., 2009; Yamayoshi
et al., 2009). SCARB2 is ubiquitously expressed and serves
as a common receptor for all clinically isolated EV71 strains,
CVA16, CVA7 and CVA14 (Yamayoshi et al., 2012). Inter-
estingly, SCARB2 was ﬁrst identiﬁed as a receptor for β-
glucocerebrosidase (β-GC) (Reczek et al., 2007) [loss-of-
function mutations of β-GC result in Gaucher disease (GD)
(Velayati et al., 2011)]. Lumenal acidiﬁcation triggers the
dissociation of β-GC from SCARB2 in late endosomal/lyso-
somal compartments in a pH-dependent manner (Zachos
et al., 2012).
Some receptors not only play a role in the attachment of
viruses to host cells, but also assist in viral uncoating (Arita
et al., 1998; Cohen et al., 2001; Hogle, 2002; Tuthill et al.,
2010). Unlike PSGL-1, SCARB2 is such an uncoating
receptor for EV71 (Yamayoshi et al., 2013). Uncoating of
EV71 is known to occur in endosomes and is tied to the
progressive acidiﬁcation of the endosome (Leong et al.,
2011; Lin et al., 2012). Intriguingly, EV71 by itself is stable
under acidic conditions (pH 4), and does not undergo any
notable pH-dependent conformational changes (Plevka
et al., 2012; Wang et al., 2012). However, SCARB2 has been
shown to trigger the uncoating process of EV71 in an acidic
environment (Chen et al., 2012; Yamayoshi et al., 2013).
This raises possibility that EV71 uncoating is induced by
conformational changes associated with SCARB2 at lower
pH values. To answer this question and shed light on the
molecular basis of SCARB2-mediated entry of EV71, struc-
tural, functional and biochemical studies were used to probe
the receptor-virus interaction. We report here structures of
SCARB2 under neutral and acidic pH, revealing pH-depen-
dent conformational changes at viral binding domain and
identify the binding interface between SCARB2 and EV71.
Together with that SCARB2 can only dislodge natural lipids
from EV71 virions and trigger viral uncoating at acidic con-
ditions, these allow us to propose an evidence-based
mechanism for receptor-mediated viral uncoating.
RESULTS
Structures of SCARB2 under neutral and acidic pH
conditions reveal a pivotal conformational change
To gain an understanding of the molecular basis of SCARB2-
mediated uncoating of EV71 under acidic conditions, we
solved the crystal structures of the ectodomain of SCARB2
under both neutral (pH 7.5) (hereafter denoted as
nSCARB2) and acidic conditions (pH 4.8) (hereafter denoted
as aSCARB2) (Fig. 1 and Table S1). As expected, the overall
structures of nSCARB2 and aSCARB2 are similar. SCARB2
(residues 37–430) consists of three domains arranged in a
“Kidney” shape (Fig. 1B and 1C). Domain I comprises resi-
dues 37–69, 81–125, 334–390 and 403–429 and primarily
contributes to a long twisted β-barrel structure at the core of
the protein. Domain II, encompassing residues 206–333,
contributes to the structural elements that complete the
atypical β-barrel (Fig. 1B and 1C). A long tunnel that tra-
verses the entire length of the protein from the membrane
proximal end to the surface of the ectodomain passes
through the hollow core of this β-barrel (Fig. 1E and 1F).
Domain II harbors ﬁve glycosylation sites and two disulﬁde
bridges (C274–C329 and C312–C318). Domain III is smaller
and consists of residues 126–205, 70–80 and 391–402.
Notably, a cluster of three helices (α4, α5 and α7) from this
domain cap one end of the tunnel formed by domains I and
II. Previous biochemical and mutagenesis studies suggest a
role for amino acids from this “cap” in the interaction of
SCARB2 with its ligands like β-GC and EV71 (Chen et al.,
2012; Reczek et al., 2007).
The structure of aSCARB2 (pH 4.8) is similar to the
recently published pH 5.5 structure [PDB code: 4F7B
(Neculai et al., 2013)], with an r.m.s. deviation of 0.41 Å.
Given the relatively low resolution of the present analysis
(∼3.7 Å, See Supplementary Information), this is at the level
of experimental error and suggests that the speciﬁc features
of the acidic structure observed are not artifacts of particular
crystallization conditions. In contrast the elucidation of the
structure of nSCARB2 (pH 7.5) at higher resolution (3.0 Å)
and its comparison with aSCARB2 enabled us to visualize a
pivotal conformational change in SCARB2 induced by pH
that has implications for the function of the receptor. A
striking difference in the position of the “cap” is observed
between structures at acidic and neutral pH. In particular,
helices α4 and α5, which are part of the β-GC binding site
(residues 150–167) (Reczek et al., 2007) and most of the
mapped EV71 binding site (residues 144–151) (Chen et al.,
2012) assume different conformations.
Transport through the lipid transfer tunnel of SCARB2
is regulated by pH
SCARB2 harbors a large cavity that is believed to serve as a
route for transporting lipids in a way similar to the lipid-
transfer tunnels of CD36 and SR-BI (Neculai et al., 2013).
The structure of aSCARB2 reveals a penetrable tunnel,
which traverses the entire length of the molecule (Figs. 1F
and S1A). In contrast, at pH 7.5, the re-positioning of α5 in
vicinity of α4 and α7 blocks the membrane-distal end of the
tunnel, decreasing its void volume from 4,867 Å3 to 4,554 Å3
[calculated by program HOLLOW (Ho and Gruswitz, 2008)]
(Figs. 1E, 1F, S1A and S1B). Thus in nSCARB2, α5 (resi-
dues 157–164) adopts a short helical conformation. The “S”
shaped linker (residues 148–155) connecting α4 with α5 is
probably a key mediator of conformational changes. Helices
α4, α5 and α7 are held together in a compact cluster by
hydrophobic interactions involving residues W146, L152,
I156, Y163 of α4–α5 and I184, L187, I188, F191, I195 from
α7. In contrast, under acidic conditions, we propose that an
alteration in the protonation state of H150 triggers the re-
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arrangement of the linker region connecting α4 with α5 such
that the linker is now part of α5. Helix α4 is shortened in
length, giving rise to a new linker (residues 146–150), that
folds away from α7, connecting a much longer α5 with α4
(Fig. 1D). More importantly, α5 moves towards α15 and
together with the conformational change of W146, extends
the lipid-transfer tunnel right through to the membrane-distal
end of the molecule with an open entrance. This movement
is facilitated by formation of new hydrogen bonds by R153
and E157. Additional electrostatic interactions between
H150 and K161 of α5 and D394 and E397 of α15 further
assist in the movement of α5. Histidine residues have been
implicated in SCARB2’s pH-dependent binding to β-GC
(Zachos et al., 2012) and H150 is well positioned to act as a
pH sensor for triggering conformational changes that regu-
late ligand binding.
In summary, helices α5 and α7 act as gatekeepers for
enforcing a pH dependent opening and closing of the tunnel.
Notably, although the tunnel is predominately hydrophobic,
the top half is lined by a number of hydrophilic residues that
are exposed to the solvent and is large enough to accom-
modate fatty acid molecules like sphingosine (Fig. S1C–E).
A fatty acid-like molecule known as the “pocket factor”
[presumed to be sphingosine in EV71 (Wang et al., 2012)]
was shown to bind into a hydrophobic pocket beneath the
canyon of EVs (Rossmann et al., 2002; Wang et al., 2012).
Receptor binding at the canyon dislodges this viral “pocket
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Figure 1. Overview of the structures and characteristics of SCARB2. (A) Schematic diagram of domain organization of SCARB2.
TM, transmembrane domain; LD, luminal domain; CD, cytoplasmic domain. The overall structures of nSCARB2 (B) and aSCARB2
(C) are shown as cartoons. Domain I, II and III are colored in orange, violet and lemon, respectively. Glycans, cysteine residues and
disulﬁde bonds are depicted as colored sticks. Helices α5 of nSCARB2 and aSCARB2 are highlighted in red and slate respectively.
(D) Superposition of domain III of nSCARB2 and aSCARB2. The residues making ionic interactions and hydrophobic interactions are
shown as colored sticks. The luminal tunnels of nSCARB2 (E) and aSCARB2 (F) were generated by HOLLOW (Ho and Gruswitz,
2008) software and are shown as blue mesh. See also Fig. S1 and Table S1.
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et al., 2013; Zhang et al., 2008). Since EV71 uncoating
occurs under acidic conditions, it is conceivable that acidic
conditions ﬁrst convert the lipid transfer tunnel of SCARB2
from a closed form as seen in nSCARB2 to an open form as
observed in aSCARB2, permitting SCARB2 to suck the
“pocket factor” from the viral capsid and thus initiate the
uncoating process of EV71.
SCARB2 dislodges “pocket factor” from EV71 virion
To prove that SCARB2 initiates uncoating of EV71 by
removing the “pocket factor” from EV71 virions, we incu-
bated mature virions with excessive [3H]-labeled sphingo-
sine (Fig. S2). The natural lipid present in the capsid of the
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Figure 2. SCARB2-mediated expulsion of lipid from EV71 virions triggers conformational change of EV71 mature virions
under acidic conditions. Competitive displacement of natural lipid from EV71 capsid proteins using [3H]-labeled sphingosine.
(A) Time dependence of competitive [3H]-labeled sphingosine binding to EV71 mature virions. Puriﬁed EV71 mature virions were
incubated with [3H]-labeled sphingosine (100 nmol/L) for the indicated times in PBS buffer (pH 7.4). EV71 virions were pelleted,
washed for 3 times using PBS buffer (pH 7.4) and the radioactivity associated with them was estimated. Results shown are the
mean ± SEM of three independent experiments. (B) Time dependence of [3H]-labeled sphingosine release from EV71 mature virions
in the presence of SCARB2 under acidic conditions. EV71 mature virions bearing [3H]-labeled sphingosine were incubated with Ni-
NTA beads in the absence or presence of an excess of recombinant SCARB2 (with a His tag) in acidic pH buffer (pH 5.0) at 37°C for
the indicated times. Differential ultracentrifugation was used to pellet EV71 particles. Radioactivity and protein content was estimated.
Results shown are the mean ± SEM of three independent experiments. The sedimentation coefﬁcients of EV71 virions were
measured by using analytical ultracentrifugation (AUC). (C) EV71 virions were suspended in neutral pH buffer (pH 7.4) or in acidic pH
buffer (pH 5.0); (D) EV71 virions were incubated with SCARB2 under neutral condition (pH 7.4) or under acidic condition (pH 5.0) at
37°C for 1 h; (E) EV71 virions were pretreated using NLD compound, and then incubated with SCARB2 under neutral condition (pH
7.4) or under acidic condition (pH 5.0) at 37°C for 1 h. Assays carried out under neutral pH buffer (pH 7.4) and acidic condition (pH
5.0) are presented in blue and red curves, respectively. See also Fig. S2.
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time dependent manner. Next, we mixed mature virions
containing this [3H]-labeled sphingosine with excess
recombinant SCARB2-His-tag protein and Ni-NTA beads
under acidic conditions (pH 5.0). The mixture was incubated
at 37°C and aliquots were withdrawn at different time inter-
vals for analysis. SCARB2 or SCARB2-EV71 complexes
were removed from the samples by low-speed centrifuga-
tion. The Ni-NTA bead-bound His-tagged protein was sedi-
mented upon centrifugation. The supernatant containing
EV71 particles was ultracentrifuged to pellet EV71 particles.
Radioactivity associated with EV71 particles was measured
and the relative protein content of EV71 capsid was evalu-
ated by Western blot.
Figure 2A shows it takes approximately 60 h for [3H]-
labeled sphingosine to attain saturation in the capsid. How-
ever, under acidic conditions (pH 5.0), addition of recombi-
nant SCARB2 to EV71 containing [3H]-labeled sphingosine
followed by incubation of the mixture at 37°C for 1–4 h,
resulted in a rapid decrease in [3H]-labeled sphingosine in
virions when compared to the amount of radioactively
labeled sphinghosine associated with similar amount of vi-
rions incubated under identical conditions but without
SCARB2 (Fig. 2B). SCARB2 removes ∼70% and 90% [3H]-
labeled sphingosine from EV71 virions within 1 h and 4 h,
respectively, while, EV71 alone loses almost no [3H]-labeled
sphingosine at pH 5.0 solution buffer after 4 h incubation.
These results demonstrate that SCARB2 can dislodge the
“pocket factor” from the viral capsid at low pH.
SCARB2 triggers uncoating of EV71 under low pH
conditions
During the process of uncoating, the viral capsid undergoes
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Figure 3. Identiﬁcation of binding interface between EV71 and SCARB2. (A) GST pull-down assay for detecting interactions of
SCARB2 with peptides located on the outer surface of the EV71 particle in vitro. Glutathione-Sepharose beads mixed with
approximately 5 μg of GST-peptide were incubated with SCARB2. After the beads were washed, proteins that bound to the beads
were analyzed by 15% SDS-PAGE, followed by Western blot analysis. The positions of peptide-GSTand SCARB2 are marked on the
right. (B) Titration of EV71 mature virions (7 μmol/L) with synthesized peptide of SCARB2 (aa 146–166, 400 μmol/L). Raw injection
heats are shown in the top panel and the corresponding speciﬁc binding isotherm (calculated from the integrated injection heats and
normalized to moles of injectant) are shown in the bottom panels. The derived dissociation constant (Kd), stoichiometry parameter
(N), and change in molar enthalpy (ΔH) and entropy (ΔS) are also shown. (C) Peptides around the “canyon” region of EV71 interact
with SCARB2. Surface rendering of one icosahedral asymmetric unit (PDB code: 3VBH) of EV71. EV71 capsid protein VP1, VP2 and
VP3 are colored in light blue, pale green and salmon, respectively. Peptides showing stronger interaction with SCARB2 are colored in
red and peptides having a weaker afﬁnity for SCARB2 in yellow. A 5-fold axis is shown as a black line and the pocket factor (cyan)
indicated by a black arrow. See also Fig. S3 and Table S2.
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sedimentation velocity experiments. Therefore, we per-
formed analytical ultracentrifugation (AUC) studies on EV71
alone and in the presence of SCARB2. Mature virions sed-
iment at ∼160 S regardless of the pH (Fig. 2C). Under neutral
conditions (pH 7.4), addition of recombinant SCARB2 to
EV71 followed by incubation of the mixture at 37°C for 1 h,
resulted in conversion of only ∼5% of the virions into ∼125 S
particles (also known as A particles), that represent
uncoating intermediates. In contrast to this, when the pH was
lowered to 5.0 in the presence of SCARB2, almost all the
mature virions were converted to ∼125 S particles (Fig. 2D).
Remarkably, a pretreatment of the mature virions with NLD
(10 μg/mL), an EV71 “pocket factor” analog that functions as
a stabilizer of EV71 virions (De Colibus et al., 2014) inter-
fered with the uncoating process. Virions pre-treated with
NLD and incubated with SCARB2 under acidic conditions
(pH 5.0) at 37°C for 1 h exhibited a sedimentation co-efﬁcient
of ∼150 S (Fig. 2E). Since the capsid of EV71 does not
change morphology under neutral conditions, NLD binding
had no effect at neutral pH (Fig. 2E). This indicates that
conformational alternation of EV71 virions mediated by
SCARB2 at acidic pH can be locked by NLD at an early
stage. Thus uncoating of EV71 requires SCARB2, and
SCARB2 can only induce uncoating under acidic conditions.
Furthermore, SCARB2-mediated uncoating can be efﬁciently
blocked by the “pocket factor” analog NLD.
The binding interface between SCARB2 and EV71
SCARB2, located on the cell membrane, interacts with
EV71 to mediate its attachment. Although the binding sites
of PSGL-1 and heparan sulfate on EV71 particles have
been experimentally identiﬁed (Nishimura et al., 2013; Tan
et al., 2013), the nature of the amino acids interacting with
SCARB2 remains unclear. To map the location of SCARB2
binding on EV71, we investigated the virus-receptor inter-
face using GST pull-down assays. We systematically
selected 18 peptides located on the outer surface of the
EV71 particle (Table S2), including the VP1 BC loop, VP1
GH loop, VP2 EF loop and VP3 GH loop. Next, these
peptides fused with a GST tag were expressed in E. coli
and tested for their ability to bind SCARB2 using a GST
pull-down assay. The results showed that only peptides
VP1-2, VP1-6, VP1-8, VP2-2 and VP3-4 could bind to
recombinant SCARB2 (Fig. 3A and data not shown). Pep-






















































































































































Figure 4. Roles of glycosylation of SCARB2 in EV71 binding and infection. (A) Pull-down assay for the interaction of SCARB2 or
deglycosylated (DG) SCARB2 with EV71 mature virions in vitro. Ni-NTA beads mixed with approximately 3 μg of SCARB2 or
deglycosylated SCARB2 were incubated with EV71 mature virions. Similar steps as Fig. 3A were carried out and the positions of
SCARB2, DG-SCARB2 and EV71 are marked on the right. (B) Man8GlcNA2 at N325 extends to binding domain. The structure of
Man8GlcNA2 and domain III are shown in the same format as in Fig. 1. (C) Electron density maps of Man8GlcNA2 at N325 of
nSCARB2 (2FO − FC map contoured at 1.0 σ). EV71-GFP was used to infect 293A-hSCARB2 cell line pretreated with or without
PNGase F. Fluorescence of GFP was determined 16 h post infection and EV71 infectivity was calculated and normalized to the
infectivity to 293A-hSCARB2 cell line without any treatments, which was considered as 100%. (D) The levels of SCARB2 expression
on the cell membrane from 293A-hSCARB2 cell line pretreated with or without PNGase F were monitored by ﬂow cytometry assay.
(E) Binding afﬁnity comparisons of EV71 to 293A-hSCARB2 cell line pretreated with or without PNGase F. (F) Infection efﬁciency of
EV71 to 293A-hSCARB2 cell line pretreated with or without PNGase F. Results shown are the mean ± SEM of three independent
experiments for panel (D–F). See also Fig. S4.
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interaction, while peptides VP1-2 and VP2-2 interacted
more weakly (Fig. 3A). The pull-down results show that the
canyon region on the EV71 surface interacts with SCARB2
(Fig. 3C).
In addition, we demonstrated by isothermal titration cal-
orimetry (ITC) that a peptide corresponding to residues 146–
166 of SCARB2 interacted with EV71 mature virions in vitro
(Fig. 3B). Residues 146–166 of SCARB2 cover a small part
of α4, the α4, α5 linker, and the whole α5, exhibit variable
conformations at different pHs (Fig. S3). Together with the
observation that the G-H loops of VP1 and VP3 (peptides
VP1-6 and VP3-4 respectively) alter their conformations
during EV71 uncoating (Ren et al., 2013; Wang et al., 2012),
these results indicate that EV71-SCARB2 complex undergo
a series of conformational changes at the binding interface to
trigger viral uncoating as pH decreasing.
Glycosylation of SCARB2 plays a key role in receptor
binding
Glycosylationof functional receptors canplayacritical role in the
attachment of Picornaviruses to host cells (Fry et al., 1999;
Vlasak et al., 2005). To verify the role of glycosylation of
SCARB2 in EV71 infection, we tested the binding of EV71 to
293A-hSCARB2 cells pretreated with PNGase F using a ﬂow
cytometry based assay. PNGase F cleaves between the
innermost GlcNAc moiety and asparagine residues from N-









































Figure 5. Putative molecular mechanism of SCARB2-assisted attachment and uncoating of EV71. The models of complexes of
nSCARB2 (A), aSCARB2 (C) and one icosahedral asymmetric unit of EV71 (PDB code: 3VBH). VP1, VP2, VP3 and SCARB2 are
drawn in blue, green, red and violet respectively. Potential residues involved in the binding of EV71 with SCARB2 are shown as
spheres. The luminal tunnel of SCARB2 and hydrophobic pocket in VP1 from EV71 are represented as blue meshes. Pocket factor is
shown in sticks. (B) and (D) are an enlarged representation of the EV71-SCARB2 interface. See also Figs. S5 and S6.
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hSCARB2 cells pretreated with PNGase F showed similar
expression of SCARB2 on the cellular membrane when com-
pared to the untreated control cells (Fig. 4D). However, PNGase
F treated cells were impaired in their ability to bind EV71 (∼30%
reduction when compared to the untreated group) and the
infection efﬁciency decreased by ∼40% (Figs. 4E, 4F andS4C).
We also tested the binding afﬁnities between EV71 virions and
SCARB2 decorated with different levels of glycosylations by
performing in vitro pull-down assays. The results revealed that
the binding of SCARB2 to EV71 decreased dramatically as the
level of glycosylationwent down (Fig. 4A). Taken together, these
results suggest that glycosylation of SCARB2 may directly
contribute to the attachment of EV71 to host cell.
Nine N-linked glycosylation sites with variable carbohy-
drate chain lengths from one to ten hexose units could be
modeled into the structures of SCARB2. Amongst these
multiple sites, based on the contour of the electron density
and prior knowledge that lysosomal enzymes are often
modiﬁed with Man9GlcNA2-P (Kim et al., 2009), the glycan at
N325 of nSCARB2 was modeled as Man8GlcNA2 (Fig. 4C).
Similarly, the glycan at N412 was modeled as Man3GlcNA2
(Fig. S4B). N325 is located at the bottom of a cleft formed
between helices α11 and α12. Man8GlcNA2 protrudes to the
surface out of this chasm and stations itself in vicinity of the
cap. Residues from all three domains interact with this gly-
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Lipid tunnel
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Figure 6. Cartoon of SCARB2-mediated EV71 entry. SCARB2 is inserted in the membrane with the ectodomain oriented towards
the exofacial leaﬂet of the membrane. Pocket factor in VP1 is drawn as a “worm”. EV71 mature virion is shown as a purple
icosahedron, and the deep-purple bigger icosahedron represents the EV71 uncoating intermediate. (A) EV71 in the process of
attachment to the host cell membrane. (B) EV71 recognizes and interacts with cellular receptor SCARB2. (C) SCARB2 changes its
conformation to open its “lipid-binding” tunnel at low pH value (<5.5) (upon internalization and transfer to the late endosome).
(D) Expulsion of pocket factor from the viral capsid occurs. (E) Pocket factor is delivered to the membrane through the tunnel of
SCARB2, meanwhile, EV71 undergoes a series of conformational changes as part of uncoating. (F) EV71 might dissociate from
SCARB2 and form a channel in the membrane to release its RNA using the VP1 N-terminus and VP4.
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stabilized by P314, E145 and H150 (Fig. 4B). More impor-
tantly, the glycan is in proximity to EV71 binding sites of
SCARB2 and the residues interacting with Man8GlcNA2
attached to N325 have been shown to be functionally
associated with EV71 VP1 (Chen et al., 2012). This is con-
sistent with the observation that the glycosylation of
SCARB2 plays a role in viral attachment. Further, sialylated
glycans (Yang et al., 2009), heparan sulfate glycosamino-
glycan (Tan et al., 2013) and Suramin (Wang et al., 2013),
which contain –SO3
- groups, bind EV71. Therefore these
results suggest that Man8GlcNA2, with a negatively charged
group, perhaps with other glycans, may facilitate attachment
via ionic interactions with the EV71 surface.
DISCUSSION
A complex model of SCARB2 binding to EV71
Viruses latch on to receptors using conserved residues
(Rossmann et al., 2002). Members of the HEV-A sub-genus
can be divided into two major groups based on their require-
ment of SCARB2 for infection, with EV71, CVA7, CVA14 and
CVA16 using SCARB2 (Yamayoshi et al., 2012). Multiple
sequence alignment of capsid proteins of all members
belonging to HEV-A reveals that residues P96, L97, N102 of
B-C loop, D219 of G-H loop, K285, S290 located at the
C-terminus of VP1, G140, T141, E142, P147 of E-F loop of
VP2 and H180, A181, R182, D183 of G-H loop of VP3 are
highly conserved in all HEV-A viruses dependent on SCARB2
for infection (Fig. S5A). As expected, all these conserved
residues lie within the ﬁve peptides that bound SCARB2
(Fig. 3Aand3C).Moreover, someof these residueshavebeen
previously reported to play essential roles in both attachment
and uncoating (Ren et al., 2013; Wang et al., 2012).
To visualize the mode of binding of EV71 with nSCARB2
(Fig. 5A) and aSCARB2 (Fig. 5C), we constructed models of
the virus-receptor complex using HEX8.0 (Mavridis et al.,
2007). Two best models, with the lowest docking scores
(docking score: −612 and −552 kJ/mol respectively), were
selected from 25 docking conformations (See Extended
Experimental Procedures). The results of the pull-down
assay were used to evaluate if these models were reason-
able (See Extended Experimental Procedures). The result-
ing complexes involve interactions between VP1-2, VP1-6,
VP1-8 and VP3-4 of EV71 and the binding domain of
SCARB2. In addition, the interaction surface between
SCARB2 and EV71 as predicted by the model is consistent
with the results of multiple sequence alignments. Further-
more, the complexes are quite stable, remaining intact after
10 ns of molecular dynamics simulation (Fig. S5B and S5C).
According to these models of the EV71-SCARB2 complex,
the hydrophobic pocket of the EV71 VP1 capsid protein lies
adjacent to the lipid-transfer tunnel of SCARB2. In this
plausible mode of binding, helices α4 and α5 located on the
viral binding domain of SCARB2 are inserted into the canyon
of EV71 capsid, and are ﬂanked by helices α7 and α15
which sit towards the ﬁve-fold and three-fold axes of EV71,
respectively. Such a conﬁguration of the capsid with respect
to SCARB2 positions conserved residues, including N102 of
B-C loop, D219 of G-H, and K285 of the C-terminus of VP1
and R182, D183 of G-H loop of VP3 appropriately for inter-
actions with domain III of SCARB2 (Fig. 5B and 5D).
Model for SCARB2-mediated entry of EV71 into host
cell
Mature EV71 virions harbor natural lipids, referred to as
“pocket-factors”, within capsid proteins. Release of this lipid is
a pre-requisite for the correct uncoating of EV71 (Grant et al.,
1994; Smith et al., 1986). Under acidic conditions, such as
encountered in the late endosome, parts of helices α4 and α5
of the viral binding domain of SCARB2 move away from helix
α7, resulting in opening of the lipid-transfer tunnel. During viral
attachment, the tunnel is positioned such that it lies adjacent to
the hydrophobic pocket of VP1 (Fig. 5D). Conversely, under
neutral conditions,α4andα5close the lipid-binding tunnel and
block communication between the tunnel and the hydrophobic
pocket of VP1 (Fig. 5B). A working model for the role of
SCARB2 in the attachment anduncoating of EV71 canbebuilt
by combining results of our structure-function studies and
previously published biochemical data (Fig. 6).
Under physiological conditions, EV71 virions recognize
and attach to SCARB2 located on the cell membrane.
Residues from the EV71 canyon region and the viral binding
domain of SCARB2 in conjunction with glycans of SCARB2,
form this critical interaction between the virus and the
receptor (Fig. 6A and 6B). After attachment, the virions are
internalized and transferred into endosomes. Under acidic
conditions in the late endosomes, the amine “head” of
sphingosine, a putative “pocket factor”, bears a positive
charge, while α4, α5, α7 of SCARB2 and the late endosomal
membrane are negatively charged (Fig. S6A and S6B). The
pH triggered reorganization of helices α4, α5 of SCARB2
open, activate the lipid-transfer tunnel, and facilitate expul-
sion of viral “pocket factor” to trigger receptor-induced
uncoating of the viral capsid (Fig. 6C and 6D). EV71
undergoes a series of conformational changes to ﬁrst form
an uncoating intermediate (Fig. 6E); followed by the N-ter-
minus of VP1 and VP4 transiting from inside to outside,
leading to the formation of a channel in the membrane
through which the viral RNA is transported and released into
the cytoplasm (Ren et al., 2013; Wang et al., 2012) (Fig. 6F).
CONCLUSION
Our structure/functional analyses provides a series of crucial
functional insights into the role of SCARB2 in cell entry by
EV71 and several closely related type A human enterovi-
ruses. Under neutral conditions, a cap closes the entrance of
the lipid-transfer tunnel of SCARB2. When exposed to acid
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pH in the late endo/lyso-somes, the cap undergoes confor-
mational changes that lead to the opening of the lipid-
transfer tunnel. Upon opening of the lipid-transfer channel
under acidic conditions of endo/lyso-somes, SCARB2 dis-
lodges the “pocket factor” from the capsid of EV71 and
translocates it through the tunnel in a manner analogous to
lipids transported by CD36 and SR-BI. Removal of the
“pocket factor” induces uncoating of EV71.
MATERIALS AND METHODS
Crystallization
Materials, such as cells and plasmids, and methods for protein puri-
ﬁcation can be found in the Extended Experimental Procedures.
Crystals were grown at 16°C using the hanging drop vapour diffusion
method. 1 μL drops contained protein mixed with reservoir solution in
1:1 ratio. Crystals of nSCARB2 expressed in 293Tcells and Sf9 cells
were obtained fromprotein eluted in the ﬁrst peak during ion exchange
chromatography after 2–3 days in a condition containing 0.1 mol/L
HEPES pH 7.5, 25% w/v PEG 3350 and 0.1 mol/L HEPES pH 7.5,
10% v/v 2-Propanol, 20% w/v Polyethylene glycol 4000 respectively.
While crystals of aSCARB2 expressed in Sf9 cells were obtained in a
condition containing 0.2 mol/L ammonium sulfate, 0.1 mol/L sodium
acetate trihydrate pH 4.8, and 30% w/v polyethylene glycol mono-
methyl ether 2000.
Structure determination
Diffraction data sets for nSCARB2 (expressed in 293T cells and
Sf9 cells) and aSCARB2 were collected at beam line BL5A and
BL17A of the Photon Factory (PF) synchrotron facility in Japan with
the highest resolution being 3.0 Å, 2.8 Å and 3.65 Å, belonging to
space groups of C2, P21 and P21 respectively. Data sets were
processed and scaled using the HKL2000 package (Otwinowski
and Minor, 1997). Data analysis and anisotropic processing can be
found in the Extended Experimental Procedures. The initial struc-
ture solutions of nSCARB2 were obtained by molecular replace-
ment using the program Phaser v2.1 (McCoy et al., 2007) with the
crystal structure of SCARB2 (Protein Data Bank [PDB] entry: 4F7B
(Neculai et al., 2013)) as a search template. Manual model building
and reﬁnement were performed using COOT (Emsley and Cowtan,
2004) and PHENIX (Adams et al., 2010) following rigid body
reﬁnement, energy minimization, B-factor reﬁnement and group
NCS constraints. The r.m.s. deviations between the two NCS-
related subunits of nSCARB2 (expressed in 293T cells and Sf9
cells) are 0.029 Å and 0.037 Å respectively. The r.m.s. deviation
between the four NCS-related molecules of aSCARB2 are 0.028
(chain A-B), 0.021 (chain A-C) and 0.029 Å (chain A-D) respec-
tively. The structures of nSCARB2 expressed in 293T cells and Sf9
cells are almost identical with an r.m.s. deviation of 0.21 Å for all C
α atom pairs and with an r.m.s. deviation of 0.32 Å for the C α atom
pairs of the “cap”. Thus the structure of nSCARB2 (expressed in
293T cells) is selected as structural analysis to aSCARB2. Chain A
from all analyses was selected for following structural analysis.
Structural ﬁgures were drawn with the program PyMOL (DeLano,
2002).
SCARB2-mediated dislodge of [3H]-labeled sphingosine from EV71
capsid under acidic condition
EV71 production and puriﬁcation can be found in the Extend
Experimental Procedures. Competitive displacement of natural lipid
from EV71 capsid proteins using [3H]-labeled sphingosine. For each
assay, 400 μL of puriﬁed EV71 mature virions (20 μg/mL) were
incubated with 8 μL [3H]-labeled sphingosine (0.1 mCi/mL; 5 μmol/L;
American Radiolabeled Chemicals, Inc.) at room temperature for the
indicated times (1 h, 4 h, 12 h, 24 h and 60 h respectively) in PBS
buffer (pH 7.4). Then EV71 virions were pelleted, washed for 3 times
using PBS buffer (pH 7.4) and the radioactivity associated with them
was measured. Radioactivity data were further normalized to the
one of incubation for 1 h, which was considered as 100%. All
reactions reported here were repeated triple times.
400 μL of puriﬁed EV71 mature virions (20 μg/mL) pretreated with
8 μL [3H]-labeled sphingosine (5 μmol/L) for 60 h were incubated
with Ni-NTA beads in the absence or presence of mammalian
expressed SCARB2 with an His tag at a molar ratio of 60:1
(SCARB2:Virus) in acidic pH buffer (pH 5.0) at 37°C for the indicated
times (0 h, 1 h, 2 h and 4 h respectively). Centrifuged at 3000 rpm for
3 min to collect Ni-NTA beads, the supernatant was then used to
pellet EV71 particles at 45,000 rpm for 1.5 h. The radioactivity of
pelleted EV71 particles was determined, meanwhile, the relative
protein contents were estimated by Western blot. Radioactivity data
were further normalized to the one of the control group (in the
absence of recombinant SCARB2 for 0 h), which was considered as
100%. All reactions reported here were repeated triple times.
Analytical ultracentrifugation
EV71 full particles were mixed with mammalian expressed SCARB2
at a molar ratio of 1:60 at pH 7.4 and pH 5.0, respectively and then
incubated at 37°C for 1 h. The full particles alone were analyzed
under identical conditions as a control. NLD, an inhibitor of EV71
which can prevent viral uncoating was also used in this experiment
with pre-incubation with EV71 full particles at a molar ratio of 240:1
(NLD:Virus) at room temperature for 4 h and then addition of
SCARB2 as mentioned above. Sedimentation velocity experiments
were performed on a Beckman XL-I analytical ultracentrifuge at 20°C.
Different preprocessed virus samples were diluted with corre-
sponding buffer (PBS pH 7.4 or Na-Citrate pH 5.0) to 400 μL at an
A280nm absorption of about 0.4. Samples were loaded into a con-
ventional double-sector quartz cell and mounted in a Beckman four-
hole An-60 Ti rotor. Data were collected at 12,000 rpm at a wave-
length of 280 nm. Interference sedimentation coefﬁcient distributions
were calculated from the sedimentation velocity data using the
SEDFIT software program (www.analyticalultracentrifugation.com).
Role for glycosylation of SCARB2 in EV71 attachment and infection
293A-hSCARB2 cell line, which stably expressed human SCARB2
on the cell surface of 293A cells was established in our lab previ-
ously. EV71-GFP virus was prepared with enhanced green ﬂuores-
cent protein (EGFP) gene inserted into EV71 genome between virus
5′ UTR and coding region such that GFP gene can be transcribed
and translated during viral replication only. 293A-hSCARB2 cells
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were seeded in polylysine pretreated 96-well plate and cultured in
complete DMEM. One day later, the cells were treated with 0, 4 or
40 μg/mL PNGase F at 37°C for 1 h. After washing with PBS, EV71-
GFP virus was added to pretreated cells at 0.1 MOI. Sixteen hours
post incubation, the cells were photographed under ﬂuorescence
microscopy, and then digested with trypsin and ﬁxed with 4%
paraformaldehyde (PFA). The GFP positive cells were analysed by
ﬂow cytometry, which can be found in the Extended Experimental
Procedures. Deglycosylation of SCARB2 by PNGase F and the
interaction between SCARB2 and EV71 in vitro by Pull-down assay
can be found in the Extended Experimental Procedures.
Molecular modelling and molecular dynamic simulation
Protein-protein docking was used to obtain an ensemble of com-
plexes between deglycosylated aSCARB2 and capsid proteins
(VP1–3) of EV71. The results of binding interface mapping provide
directions for EV71-SCARB2 docking. More details can be found in
the Extended Experimental Procedures.
Isothermal titration calorimetry
Highly puriﬁed EV71 mature virions and the synthesized peptide (aa
146–166 of SCARB2) were in ITC buffer (PBS buffer pH 7.4). The
SCARB2 peptide (aa 146–166, 400 μmol/L) was loaded into the
syringe of the microcalorimeter (GE Company), with EV71 mature
virions in the cell at a concentration of 7 μmol/L. Injections of 10 μL
of the peptide were made into the cell at 25°C. Data were analysed
by the Origin 7 software.
ACCESSION CODES
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